GPR55 as a new cannabinoid receptor: Still a long way to prove it

Chemical Biology and Drug Design

Volumn 67, Issue 3, 2006, Pages 252-253

  Petitet, François ^a   Donlan, Mary ^a   Michel, André ^a  

^a Aureus Pharma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CP 55934; DEXANABINOL; DRONABINOL; JWH 051; JWH 057; RIMONABANT; TETRAHYDROCANNABINOL DERIVATIVE;

AMINO ACID SEQUENCE; DRUG ACTIVITY; IC 50; MUTAGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SHORT SURVEY;

HUMANS; LIGANDS; PEPTIDE MAPPING; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33645323225     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00370.x     Document Type: Short Survey

References (12)

1. Drmota Greasley Groblewski 2004 AstraZeneca. Screening assays for cannabinoid-ligand type modulators of GPR55 WO2004074844
2. 9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors Life Sci Pharmacol Lett 63 1 6
3. Jarai Wagner Varga Lake Compton Martin Zimmer et al. 1999 Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci USA 96 14136 14141
4. Fride Foox Rosenberg Faigenboim Cohen Barda Blau et al. 2003 Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a ''CB3'' receptor Eur J Pharmacol 461 27 34
5. Begg Pacher Batkai Osei-Hyiaman Offertaler Ming Mo Liu et al. 2005 Evidence for novel cannabinoid receptors Pharmacol Ther 106 133 145
6. AurSCOPE GPCR database Aureus-Pharma.
7. Murphy Kendall 2003 Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A Biochem Pharmacol 65 1623 1731
8. Tao Abood 1998 Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling J Pharmacol Exp Ther 1285 651 658
9. Huffman Yu Showalter Abood Wiley Compton Martin et al. 1996 Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor J Med Chem 39 3875 3877
10. Tao McAllister Andreassi Nowell Cabra Hurst Bachtel et al. 1999 Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity Mol Pharmacol 55 605 613
11. Gouldson Calandra Legoux Kerneis Rinaldi-Carmona Barth Le Fur et al. 2000 Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor Eur J Pharmacol 401 17 25
12. Song Feng 2002 Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its function FEBS Lett 531 290 294